Get the Stockscreener App
112.42
2.77%
-3.195
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $112.42, with a volume of 1.08M.
It is down -2.77% in the last 24 hours and down -2.30% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$115.62
Open:
$115.81
24h Volume:
1.08M
Relative Volume:
0.49
Market Cap:
$31.75B
Revenue:
$7.07B
Net Income/Loss:
$1.29B
P/E Ratio:
24.79
EPS:
4.5355
Net Cash Flow:
$993.00M
1W Performance:
+0.21%
1M Performance:
-2.30%
6M Performance:
-24.77%
1Y Performance:
+5.13%
1-Day Range:
$111.93
$115.85
1-Week Range:
$111.93
$120.28
52-Week Range:
$107.07
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
112.36 | 32.67B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
452.86 | 172.80B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
166.50 | 121.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
526.96 | 44.18B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
348.76 | 34.86B | 3.77B | 449.25M | 240.68M | 7.8556 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Agilent Technologies stock (US00846U1016): Q1 earnings miss and upcoming Q2 report - AD HOC NEWS
Agilent Technologies stock (US00846U1016): Q1 earnings miss and updated guidance - AD HOC NEWS
Crossmark Global Holdings Inc. Acquires 9,615 Shares of Agilent Technologies, Inc. $A - MarketBeat
TRADE NEWS: Agilent Technologies Introduces Industry's First LTE-Advanced 8x8 MIMO Signal-Generation - AOL.com
Agilent Taps Cirena To Turn Long RNA Technology Into Genome Editing Growth - Yahoo Finance
TRADE NEWS: Agilent Technologies Introduces New Portable Logic Analyzers - AOL.com
Is Agilent Technologies (A) Fairly Priced After Mixed Returns And DCF Upside Signals? - simplywall.st
Agilent Technologies Inc. stock (US00846U1016): FDA approval and earnings miss shape outlook - AD HOC NEWS
Generali Asset Management SPA SGR Has $7.38 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
TRADE NEWS: Agilent Technologies' Model Extraction and Qualification Software Adopted by Shanghai Co - Yahoo
Agilent Technologies Inc. stock underperforms Friday when compared to competitors - MarketWatch
[Form 3] AGILENT TECHNOLOGIES, INC. Initial Statement of Beneficial Ownership - Stock Titan
AAgilent Technologies Inc Stock Price and Quote - Finviz
Cirena licenses Agilent long RNA purification technology for high-purity genome editing workflows - Manufacturing Chemist
Dna Forensic Market Is Booming So Rapidly | Agilent Technologies, Illumina, Bio-Rad Laboratories - openPR.com
Swedbank AB Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Raises Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing - Indian Pharma Post
Robeco Schweiz AG Has $142.75 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent Taps Danaher Deal Lawyer As Chief Legal Officer - Law360
Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight - GlobeNewswire Inc.
A Stock Price Prediction 2025-2026 | Agilent Technologies Inc Forecast | 24/7 Wall St. - 24/7 Wall St.
Assessing Agilent Technologies (A) Valuation After FDA Approval Of PD L1 Assay For KEYTRUDA - Yahoo Finance
Assessing Agilent Technologies (A) Valuation After FDA Companion Diagnostic Approval For Esophageal Cancer - simplywall.st
The Bull Case For Agilent Technologies (A) Could Change Following Exclusive FDA Approval Of Its KEYTRUDA Test - Yahoo Finance
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Plucks Its New CLO From Rival's Leadership Team - Law.com
Here's what to expect from Agilent Technologies’ next earnings report - MSN
Does Agilent’s New Chief Legal Officer Shift the Risk‑Reward Balance in Its Strategy (A)? - Sahm
Agilent receives FDA approval for PD‑L1 IHC 22C3 pharmDx in esophageal and GEJ carcinoma - SelectScience
Agilent Technologies Names Michael Buckner as CLO - Yahoo Finance
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent Technologies Names Michael Buckner Chief Legal Officer - citybiz
Agilent Names Michael Buckner as Chief Legal Officer - BioSpace
Agilent Technologies Appoints Michael Buckner as Chief Legal Officer, Bringing Extensive Global Legal Experience 1 - Minichart
Agilent Names New Chief Legal Officer Amid Leadership Transition - TipRanks
Agilent appoints Michael Buckner as Chief Legal Officer; Bret DiMarco resigns - TradingView
Danaher deal lawyer Michael Buckner takes Agilent legal chief post - Stock Titan
Agilent names Michael Buckner as chief legal officer - marketscreener.com
Agilent (NYSE: A) taps Michael Buckner as new chief legal officer - Stock Titan
Strs Ohio Buys 135,212 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (A) Stock Analysis: A Promising 40% Upside Potential for Investors - DirectorsTalk Interviews
Agilent Technologies Adjusts Valuation Amidst Declining Profits and Strong Financial Metrics - Markets Mojo
M&T Bank Corp Reduces Position in Agilent Technologies, Inc. $A - MarketBeat
Danske Bank A S Sells 44,623 Shares of Agilent Technologies, Inc. $A - MarketBeat
Jennison Associates LLC Has $82.50 Million Stock Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Inc (A) Shares Surge 3.8% -- What GF Score of 95 Tells Investors - GuruFocus
Is Agilent Technologies a Good Stock to Buy? - HarianBasis.co
Is Agilent Technologies, Inc. (A) A Good Stock To Buy Now? - Insider Monkey
Agilent to acquire Biocare Medical for $950M, expanding pathology portfolio - MSN
Agilent Technologies Stock (US00846U1016): Set to Report Q2 Fiscal 2026 Results - AD HOC NEWS
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):